Events2Join

VENTANA® FOLR1


VENTANA® FOLR1 (FOLR1-2.1) RxDx Assay - Roche Diagnostics

VENTANA® FOLR1 (FOLR1-2.1) RxDx Assay · First IHC companion diagnostic for determining folate receptor alpha (FOLR1) protein expression in EOC patients who may ...

VENTANA FOLR1 RxDx IHC Assay helps you ... - Roche Diagnostics

The first FDA-approved immunohistochemistry companion diagnostic test that helps you detect the Folate Receptor (FOLR1) biomarker in patients with epithelial ...

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx ...

The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay detects the folate receptor 1 protein (FOLR1 or FRɑ), which is over-expressed in most ovarian ...

453006 FOLR1 Immunohistochemistry Analysis | Labcorp Oncology

VENTANA FOLR1 RxDx Assay is an immunohistochemical assay using mouse monoclonal anti-FOLR1-2.1, intended for use in the assessment of folate receptor alpha ( ...

VENTANA FOLR1 (FOLR1-2.1) RxDx Assay - accessdata.fda.gov

The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay antibody demonstrates cytoplasmic and membranous staining. However, only membrane staining is evaluated ...

VENTANA FOLR1 (FOLR-2.1) RxDx Assay – P220006 - FDA

What is it? VENTANA FOLR1 (FOLR-2.1) RxDx Assay is a laboratory test designed to detect folate receptor alpha (FOLR1) protein in patients with ...

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx ...

The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay detects the folate receptor 1 protein (FOLR1 or FRɑ), which is over-expressed in most ovarian cancers.

FOLR1 FDA (ELAHERE™) for Ovarian Carcinoma

The FOLR1 FDA (ELAHERE) for Ovarian Carcinoma test utilizes VENTANA FOLR1 CDx to determine FRα expression in ovarian cancer.

FOLR1 IHC Testing - Foundation Medicine

The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay is for prescription use only and is a qualitative IHC assay intended for use in the assessment of folate receptor ...

Roche's VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Gets CE Mark ...

(RTTNews) - Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

FR-ASSIST™ FOLR1 IHC Sponsored Testing Program

The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay is the first and only immunohistochemistry (IHC) assay that is FDA approved to identify tumors with FOLR1 expression.

FOLR1 Ovarian Cancer Testing Program - NeoGenomics Laboratories

When using the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay for the evaluation of ovarian cancer patients, approximately 35% of patients are considered to have high ...

VENTANA FOLR1 (FOLR1-2.1) RxDx Assay - SelectScience

Read independent reviews on the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay from Roche on SelectScience.

TEST: VENTANA FOLR1 RxDx Assay - LARVOL VERI

Details ... his assay is for use with OptiView DAB IHC Detection Kit for staining on a BenchMark ULTRA instrument. This assay is indicated as an aid in ...

Development of an FRα Companion Diagnostic ... - PubMed

—: The VENTANA FOLR1 Assay is a robust and reproducible assay for detecting FRα expression and identifying a patient population that derived clinically ...

Roche receives FDA approval for VENTANA FOLR1 ... - PR Newswire

The first immunohistochemistry (IHC) companion diagnostic test to aid in identifying epithelial ovarian cancer (EOC) patients who are eligible for targeted ...

FOLR/FRα Companion Diagnostic Testing Program - Myriad Genetics

*Full name = VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. Patient Eligibility Criteria: Eligible patients may receive one (1) FOLR1/FRα immunohistochemistry for ...

FOLR1 (FOLR1-2.1) | Sonic Healthcare USA Anatomical Pathology

The mouse monoclonal primary antibody in the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay binds to the FOLR1 protein in paraffin-embedded tissue sections. The ...

Development of an FRα Companion Diagnostic ...

The VENTANA FOLR1 Assay was used in the ImmunoGen Inc–sponsored SORAYA study to select patients for treatment with mirvetuximab soravtansine (MIRV) in platinum ...

Ventana Precision Oncology News

FDA Approves ImmunoGen's Elahere for Folate Receptor Alpha-Positive Ovarian Cancer. The FDA also approved Roche's Ventana FOLR1 (FOLR1-2.1) RxDx Assay as a ...